The Consult · July 29, 2026 · 8 min · By Bennett Oyinlola
Under-eye filler while you are still losing weight: the timing question nobody asks
The tear trough is filled to a shape. Rapid pharmacologic weight loss keeps changing that shape for months after the injection. Almost every consultation covers what filler does and none of them cover what your face is going to do underneath it.

She is eleven weeks into a GLP-1 medication, down a meaningful amount of weight, and the thing that bothers her is her face. Specifically the hollow under each eye, which she says appeared over about six weeks and which she never had before. She has booked a tear trough appointment. The question she asks, almost apologetically, is whether this is a good idea, and she asks it because some part of her already suspects the answer is complicated.
It is complicated, and the reason is simple once stated. Under-eye filler is a volume replacement placed into a defined anatomical deficit. She does not have a defined deficit. She has a moving one.
The original element in this piece is a three question timing check, applied before the injection rather than after, that sorts the decision into inject now, inject a reduced volume now, or wait. No clinic publishes this because the published literature on facial change during GLP-1 weight loss is barely three years old and consists mostly of descriptive and review work rather than treatment timing guidance. The gap is real and patients are walking into it in large numbers right now.
What is actually changing in the face. Facial fat is not one uniform layer. It is organized into discrete compartments, and the compartments around the eye, cheek and temple are among the first to show loss when body fat drops quickly. That is the anatomical basis of what the public calls Ozempic face, and it has been described in the aesthetic literature as accelerated facial and skin aging associated with GLP-1 receptor agonists. A systematic review of the phenomenon in plastic surgery confirms both that the effect is consistently reported and that the evidence base is thinner than the volume of discussion about it suggests.
The important mechanical point for the under-eye specifically is that the tear trough is not a hollow in isolation. It is the boundary between the lower eyelid and the cheek, and how deep it reads depends heavily on how full the cheek immediately below it is. Lose volume in the medial cheek and the trough deepens without anything happening to the trough itself. Fill the trough while the cheek is still emptying, and three months later the filler is sitting at the correct depth relative to a cheek that has since dropped, which reads as a ridge or a step rather than a smooth transition.
This is the same anatomical relationship that makes the tear trough a harder region than it looks, and rapid weight loss turns a static problem into a moving one.
The three question timing check. Ask these in order, before anything is drawn up.
Question one: are you still titrating, or are you at a stable dose. Dose escalation on these medications is deliberately gradual, and the steepest rate of weight loss typically occurs during and shortly after escalation. If you are still climbing through doses, your face is on the steepest part of its own curve. Answer: wait.
Question two: what has your weight done over the last eight weeks, in numbers, not impressions. Not total loss, the recent slope. If you are still losing at a meaningful clip, whatever is filled today is being filled against a face that will look different by the time the swelling has fully settled. If the last eight weeks are flat or nearly flat, the shape you are treating is close to the shape you will keep. Answer: flat means proceed, still dropping means wait or reduce.
Question three: is the hollow you are pointing at actually in the trough, or is it in the cheek below it. Look in a mirror in front light and place a fingertip at the deepest point. If it sits on the bone at the inner corner along the orbital rim, that is a trough. If it sits a centimetre or more below, on the cheek, filling the trough will not fix it and may make the boundary above it more obvious. Answer: cheek means the under-eye is the wrong target entirely.
Two yeses and a correctly located trough is a reasonable go. One no on either of the first two questions is a reason to wait, and waiting is not a lost cause: a face that has been weight stable for two to three months is a far easier face to treat well, and the work costs the same either way.
If you decide to proceed anyway. Some people will, for reasons that are legitimate, and there is a defensible way to do it. Treat conservatively and undercorrect deliberately, on the understanding that this is a first pass rather than a finished result, with a planned review. Consider whether the cheek should be addressed first or simultaneously, since restoring the platform below often reduces how much the trough needs. And know in advance that this is a hyaluronic acid product, which means it is reversible, and that reversibility is the reason this is a recoverable decision rather than a permanent one. If the shape moves out from under it, the answer is dissolving and starting again on a stable face, which is a genuine option rather than a consolation.
Understand also that hyaluronic acid in this region is hydrophilic and holds water, so the settling period is longer here than most patients expect, and judging the result at two weeks on a face that is still losing weight compounds two moving variables at once.
What the studies do not tell you. There is no published data on filler longevity, migration or satisfaction in patients undergoing active pharmacologic weight loss. None. The reviews of GLP-1 agents in aesthetic medicine describe the volume loss and discuss treatment options in general terms, but no study has followed a cohort injected during active weight loss against a cohort injected after stabilization. Whether product placed during a period of rapid fat loss behaves differently is genuinely unknown.
There is also no consensus definition of weight stable for this purpose. The two to three month figure that experienced injectors use is clinical judgment, not a validated threshold, and anyone quoting it to you including this article should say so.
The takeaway. The medication is doing something to your face on a timeline of months, and filler is a decision made in a single afternoon. Matching those two clocks is the entire question, and it is answerable with three questions and a mirror before you spend anything. If you are still climbing doses or still dropping weight week over week, the best possible version of this treatment is the one you have not had yet. That is worth more than a good result today that needs correcting in the spring, and it is the kind of thing a good consultation should raise before you do.